Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • 5-year survival rate for HIV-infected patients with invasive anal cancer earlier in HAART era: 47%[Bower 2004]
    • Later HAART era study demonstrated 70% 5-year OS rate in HIV-infected patients with invasive anal canal cancer vs 69% in matched controls[Oehler-Jänne 2006]
    • OS negatively associated with high HIV-1 RNA level and low CD4+ cell count

Action required